Experimental and Clinical Endocrinology & Diabetes · 2007 · 19 citations · 0 references
Life SciencesEndocrinologyImmunologyAutoimmunityImmunopathologyNeuroendocrinologyAdrenal DisordersAdrenal EndocrinologyAdrenal HormonesAutoimmune Disease DiagnosticsAutoimmune DiseasesAutoimmune EndocrinopathiesAdrenal PathophysiologyAntibodiesAutoimmune Addison DiseaseAutoimmune Endocrine PathologyDiagnostic Follow-upEndocrine Organ-specific AutoantibodiesSubclinical HypothyroidismThyroid Peroxidase Antibodies
OBJECTIVE: To report a patient with autoimmune adrenal disease and increased ACTH with longstanding hyperpigmentation as an isolated symptom. METHODS: A 49-year-old woman requested a diagnostic work-up for hyperpigmentation initiated 9 years before, associated with increased ACTH. She was receiving replacement therapy for autoimmune hypothyroidism. Basal and dynamic tests of glucocorticoid axis, basal investigation of mineralocorticoid axis and measurement of organ specific autoantibodies were performed. RESULTS: Plasma ACTH (143 pmol/l; normal <13.2 pmol/l) and antibodies against 21-hydroxylase (115 UI/ml; normal <1) were remarkably high, thyroid peroxidase and parietal cell antibodies were positive at low titer and all additional tests were normal. CONCLUSION: Autoimmune adrenal disease can have a very long preclinical period even with high concomitant ACTH and specific antibody titers.